跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
力百汀 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Amoxicillin Sodium and Clavulanate Potassium for Injection
Approved
化学药品
Amoxicillin Sodium and Clavulanate Potassium for Injection
SMITHKLINE BEECHAM LIMITED
🇨🇳 National Medical Products Administration
Approval Date
May 15, 2015
Approval ID
7MazXbORypp
Company
SMITHKLINE BEECHAM LIMITED
Type
化学药品
Approval Details
Approval Id
7MazXbORypp
Approval Number
H20150305
Generic Name
注射用阿莫西林钠克拉维酸钾
Generic Name En
Amoxicillin Sodium and Clavulanate Potassium for Injection
Trade Name
力百汀
Drug Type
化学药品
Dosage Form
注射剂
Strength
0.6g(阿莫西林0.5g与克拉维酸0.1g)
Reg Date
2015-05-15
Expired Date
2020-05-14
Company Name
SMITHKLINE BEECHAM LIMITED
Company Address
980 Great West Road, Brentford, Middlesex, TW8 9GS
Production Company Name
SMITHKLINE BEECHAM LIMITED
Production Company Address
Clarendon Road, Worthing, West Sussex, BN14 8QH
Company Detail Path
/organization/smithkline-beecham-limited
Production Company Detail Path
/organization/smithkline-beecham-limited
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
May 15, 2015
Approval ID
7MazXbORypp
Type
化学药品
Back to NMPA Approvals
